Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP882979.RAzOt_dMKhY2x7AFV615AkQE6wpisT1bMkFe_-XlaWs-A130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP882979.RAzOt_dMKhY2x7AFV615AkQE6wpisT1bMkFe_-XlaWs-A130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP882979.RAzOt_dMKhY2x7AFV615AkQE6wpisT1bMkFe_-XlaWs-A130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP882979.RAzOt_dMKhY2x7AFV615AkQE6wpisT1bMkFe_-XlaWs-A130_provenance.
- NP882979.RAzOt_dMKhY2x7AFV615AkQE6wpisT1bMkFe_-XlaWs-A130_assertion description "[These results suggest that FGF21 could be a novel and attractive drug candidate for the treatment of cardiovascular disease, obesity and type 2 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP882979.RAzOt_dMKhY2x7AFV615AkQE6wpisT1bMkFe_-XlaWs-A130_provenance.
- NP882979.RAzOt_dMKhY2x7AFV615AkQE6wpisT1bMkFe_-XlaWs-A130_assertion evidence source_evidence_literature NP882979.RAzOt_dMKhY2x7AFV615AkQE6wpisT1bMkFe_-XlaWs-A130_provenance.
- NP882979.RAzOt_dMKhY2x7AFV615AkQE6wpisT1bMkFe_-XlaWs-A130_assertion SIO_000772 19337957 NP882979.RAzOt_dMKhY2x7AFV615AkQE6wpisT1bMkFe_-XlaWs-A130_provenance.
- NP882979.RAzOt_dMKhY2x7AFV615AkQE6wpisT1bMkFe_-XlaWs-A130_assertion wasDerivedFrom befree-20150227 NP882979.RAzOt_dMKhY2x7AFV615AkQE6wpisT1bMkFe_-XlaWs-A130_provenance.
- NP882979.RAzOt_dMKhY2x7AFV615AkQE6wpisT1bMkFe_-XlaWs-A130_assertion wasGeneratedBy ECO_0000203 NP882979.RAzOt_dMKhY2x7AFV615AkQE6wpisT1bMkFe_-XlaWs-A130_provenance.
- befree-20150227 importedOn "2015-02-27" NP882979.RAzOt_dMKhY2x7AFV615AkQE6wpisT1bMkFe_-XlaWs-A130_provenance.